VivoSim Labs
VIVS
117 hedge funds and large institutions have $67M invested in VivoSim Labs in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 36 increasing their positions, 28 reducing their positions, and 9 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 28
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
2% more funds holding
Funds holding: 115 → 117 (+2)
0.01% more ownership
Funds ownership: 0.1% → 0.1% (+0.01%)
13% less capital invested
Capital invested by funds: $76.7M → $67M (-$9.66M)
65% less call options, than puts
Call options by funds: $343K | Put options by funds: $989K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$2.32M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$617K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$576K |
| 4 |
State Street
Boston,
Massachusetts
|
+$423K |
| 5 |
BlackRock
New York
|
+$297K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$465K |
| 2 |
QIM
Quantitative Investment Management
Charlottesville,
Virginia
|
-$396K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$326K |
| 4 |
QI
Quotient Investors
New York
|
-$285K |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$238K |
VIVS Hedge Fund Activity: Q2 2017 in Review
117 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q2 2017, worth a combined $67M — down 13% from $76.7M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new VIVS positions and 9 closed out — a net gain of 2 holders — while 36 added to existing stakes and 28 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $2.32M. The largest seller was Morgan Stanley, cutting an estimated $465K.
- 117 institutional investors held VivoSim Labs (VIVS) as of Q2 2017, up from 115 in Q1 2017.
- Funds reported $67M of VivoSim Labs stock for Q2 2017, down 13% quarter-over-quarter.
- 11 funds opened new VivoSim Labs positions in Q2 2017 and 9 closed out, a net change of +2 holders.
- The largest VivoSim Labs buyer in Q2 2017 was ARK Investment Management, an estimated $2.32M added.
- The largest VivoSim Labs seller in Q2 2017 was Morgan Stanley, an estimated $465K sold.
Based on aggregated 13F filings for Q2 2017.